ORGANOGENESIS HOLDINGS INC (ORGO:NASDAQ)
$2.67 0.18 (7.2289%)
Analysed ORGANOGENESIS HOLDINGS INC (ORGO:NASDAQ) News Sources
Organogenesis Completes Rolling Submission of Biologics License Application for ReNu®
28-04-2026
yahoo.com
Organogenesis Holdings Inc. Reports First Quarter 2026 Financial Results
07-05-2026
yahoo.com
Organogenesis Q1 Earnings Call Highlights
08-05-2026
marketbeat.com
Organogenesis Holdings Inc. Q1 2026 Earnings Call Summary
08-05-2026
moby.co
Organogenesis (ORGO) Q1 2026 Earnings Transcript
08-05-2026
fool.com
Undervalued Small Caps With Insider Buying To Watch In May 2026
14-05-2026
yahoo.com
Spotlight On Penny Stocks To Consider In May 2026
14-05-2026
yahoo.com
Is Organogenesis Holdings Inc. (ORGO) Losing Momentum? BTIG Pulls Buy Rating After Q1 Update
20-05-2026
yahoo.com
Organogenesis Announces FDA Acceptance of Biologics License Application for ReNu® for the Management of Symptomatic Knee Osteoarthritis
06-07-2026
yahoo.com
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026
09-07-2026
yahoo.com
What is the current price of ORGANOGENESIS HOLDINGS INC (ORGO:NASDAQ)?
The current price of ORGANOGENESIS HOLDINGS INC (ORGO:NASDAQ) is $2.67.
ORGANOGENESIS HOLDINGS INC (ORGO:NASDAQ) absolute price change since previous trading day?
The absolute price change of ORGANOGENESIS HOLDINGS INC (ORGO:NASDAQ) since the previous trading day is $0.18.
ORGANOGENESIS HOLDINGS INC (ORGO:NASDAQ) percentage price change since previous trading day?
The percentage price change of ORGANOGENESIS HOLDINGS INC (ORGO:NASDAQ) since the previous trading day is 7.2289%.
What is the most recent average sentiment score for ORGANOGENESIS HOLDINGS INC (ORGO:NASDAQ)?
The most recent average sentiment score for ORGANOGENESIS HOLDINGS INC (ORGO:NASDAQ) is 71 out of 100.
What is the most recent average sentiment for ORGANOGENESIS HOLDINGS INC (ORGO:NASDAQ)?
The most recent sentiment for ORGANOGENESIS HOLDINGS INC (ORGO:NASDAQ) is .
SEC-8K** Filing Available For ORGANOGENESIS HOLDINGS INC (ORGO:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.